nicorandil has been researched along with Necrosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Kashef, DH; Sharawy, MH | 1 |
| Galiñanes, M; Lai, VK | 1 |
| Araki, S; Izumiya, Y; Kaikita, K; Kojima, S; Matsubara, J; Nagayoshi, Y; Ogawa, H; Sakamoto, K; Sugiyama, S; Tsujita, K; Usuku, H | 1 |
| Asakura, M; Asanuma, H; Jiyoong, K; Kitakaze, M; Minamino, T; Shintani, Y | 1 |
| Ikegaki, I; Sasaki, Y; Uchida, T; Yamamoto, Y | 1 |
1 trial(s) available for nicorandil and Necrosis
| Article | Year |
|---|---|
Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage
Topics: Adult; Aged; Biomarkers; Cardiac Surgical Procedures; Clinical Protocols; Creatine Kinase; Data Collection; Electrocardiography; Humans; Middle Aged; Myocardial Infarction; Necrosis; Nicorandil; Potassium Channels; Reperfusion Injury; Research Design; Sample Size; Troponin T; Ventricular Function, Left | 2004 |
4 other study(ies) available for nicorandil and Necrosis
| Article | Year |
|---|---|
Hepatoprotective effect of nicorandil against acetaminophen-induced oxidative stress and hepatotoxicity in mice via modulating NO synthesis.
Topics: Acetaminophen; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Liver; Mice; Necrosis; Nicorandil; Nitric Oxide; Oxidative Stress | 2023 |
Protection of human myocardium by bone marrow cells: role of long-term administration of the mitochondrial K(ATP) channel opener nicorandil.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Atrial Appendage; Bone Marrow Cells; Cardiotonic Agents; Cell Communication; Humans; In Vitro Techniques; Middle Aged; Myocardial Ischemia; Necrosis; Nicorandil; Potassium Channels; Vasodilator Agents | 2011 |
Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angina Pectoris; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cardiovascular Agents; Cells, Cultured; Chi-Square Distribution; Coronary Artery Disease; Cytokines; Disease Models, Animal; Drug Administration Schedule; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endothelial Cells; Fibrosis; Humans; Inflammation Mediators; Japan; Lipids; Logistic Models; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Molecular Chaperones; Necrosis; Nicorandil; Odds Ratio; Retrospective Studies; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Movement; Diltiazem; Electrocardiography; Endothelin-1; Enzyme Inhibitors; Heart Ventricles; Macrophages; Male; Microscopy; Myocardial Ischemia; Necrosis; Neutrophils; Nicorandil; Nifedipine; Papillary Muscles; Rabbits; Random Allocation; Vasodilator Agents | 2000 |